Latest News

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy

Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the online Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator.

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy - Read More…

Virtual Reality Shows Promise for Early Detection of MS Balance Problems

Virtual Reality Shows Promise for Early Detection of MS Balance Problems

The UNC School of Medicine lab of Jason Franz, PhD, created virtual reality experiments to show how a potentially portable and inexpensive test could reduce falls and related injuries in people with multiple sclerosis.

Virtual Reality Shows Promise for Early Detection of MS Balance Problems - Read More…

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases

Led by UNC School of Medicine neuroscientist Hyejung Won, PhD, researchers created H-MAGMA, a computational tool that improves current technology used to link non-coding genetic variants to the genes associated with diseases through genome-wide association studies.

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases - Read More…

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership

This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and pharmaceutical research scientists together for the goal of curing people with HIV. David Margolis, MD, is the director of the UNC Cure Center.

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership - Read More…

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA

Based on proof-of-concept results from clinical trials at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA - Read More…

North Carolina’s Early Check Program to Add New Muscular Dystrophy Test to Newborn Screening Panel

North Carolina’s Early Check Program to Add New Muscular Dystrophy Test to Newborn Screening Panel

The test will identify Duchenne muscular dystrophy and some other types of muscle conditions, as part of the Early Check Program, which is led at UNC-Chapel Hill by Cynthia Powell, MD.

North Carolina’s Early Check Program to Add New Muscular Dystrophy Test to Newborn Screening Panel - Read More…

Five-year survival improves for certain cancers in adolescents and young adults

Five-year survival improves for certain cancers in adolescents and young adults

UNC Lineberger's Hazel Nichols, PhD, is senior author of a report in the Journal of the National Cancer Institute that shows which cancer types saw improved outcomes among adolescents and young adults.

Five-year survival improves for certain cancers in adolescents and young adults - Read More…

CAR-T therapy gives patient options after cancer returns

CAR-T therapy gives patient options after cancer returns

When Sabrina Shelton exhausted traditional treatment options, her care team at UVA referred her to UNC Lineberger’s Matthew Foster, MD, for a chimeric antigen receptor T-cell (CAR-T) therapy clinical trial. Watch the video and read the story about her journey.

CAR-T therapy gives patient options after cancer returns - Read More…

UNC Health Care is now “UNC Health”

UNC Health Care is now “UNC Health”

The UNC Health system introduced a new name, new logo, and new commitment to transformational change.

UNC Health Care is now “UNC Health” - Read More…

UNC School of Medicine NIH Funding Jumps More Than $23 Million  in Federal FY 2019

UNC School of Medicine NIH Funding Jumps More Than $23 Million in Federal FY 2019

All six basic science departments rank in the top 10 in National Institutes of Health funding, according to a new report by the Blue Ridge Institute for Medical Research, and 12 clinical departments rank in the top 30.

UNC School of Medicine NIH Funding Jumps More Than $23 Million in Federal FY 2019 - Read More…

Researchers implicate gene in DNA errors in aggressive breast cancer

Researchers implicate gene in DNA errors in aggressive breast cancer

Researchers led by UNC Lineberger Comprehensive Cancer Center’s Gaorav Gupta, MD, PhD, described the role of a mutation in the Mre11 gene in triple negative breast cancer and how a disruption of Mre11 function plays a significant role in the genomic instability of that cancer type.

Researchers implicate gene in DNA errors in aggressive breast cancer - Read More…

Approval Processes for Clinical Practice Guidelines Introduce Potential Conflicts of Interest, Review Finds

Approval Processes for Clinical Practice Guidelines Introduce Potential Conflicts of Interest, Review Finds

The study led by UNC’s Jeffrey Sonis, MD, MPH, in the departments of social medicine and family medicine, finds that most of the approval processes used by medical specialty societies in the U.S. have the potential to undermine editorial independence of the guideline development committee.

Approval Processes for Clinical Practice Guidelines Introduce Potential Conflicts of Interest, Review Finds - Read More…

A New Jetlag Drug? Scientists Create Selective Molecules to Bind to Melatonin Receptors

A New Jetlag Drug? Scientists Create Selective Molecules to Bind to Melatonin Receptors

Researchers from the UNC School of Medicine, UC San Francisco, and the University of Buffalo used 3-D computer simulations and pharmacological experiments to create molecules that selectively target the MT1 melatonin receptor to modulate the biological clocks in animal models of jet lag. Bryan L. Roth, MD, PhD, is co-senior author.

A New Jetlag Drug? Scientists Create Selective Molecules to Bind to Melatonin Receptors - Read More…

UNC School of Medicine Announces New Class of FIRST Scholars

UNC School of Medicine Announces New Class of FIRST Scholars

The Fully Integrated Readiness for Service Training (FIRST) is a three-year medical school curriculum to fast-track UNC School of Medicine students into UNC Family Medicine Residency, followed by three years of service in NC with ongoing support in practice.

UNC School of Medicine Announces New Class of FIRST Scholars - Read More…

Key Molecular Machine in Cells Pictured in Detail for the First Time

Key Molecular Machine in Cells Pictured in Detail for the First Time

Histone mRNA-cleaving machine, crucial for healthy cell division, yields up its secrets after almost half a century of research. Zbigniew Dominski, PhD, and William Marzluff, PhD, led this effort at the UNC School of Medicine, along with key collaborators at Columbia University and Rockefeller University.

Key Molecular Machine in Cells Pictured in Detail for the First Time - Read More…

Researchers develop method to engineer immune cells so they grow even in hostile tumors

Researchers develop method to engineer immune cells so they grow even in hostile tumors

Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, report in the journal Nature Biotechnology they have created a method for providing a stimulatory signal to super-charge cancer-hunting immune cells, called chimeric antigen receptor T-cells, that have been genetically engineered to hunt and kill specific cancers.

Researchers develop method to engineer immune cells so they grow even in hostile tumors - Read More…

Study finds blood test accurately tracks HPV-linked head and neck cancer

Study finds blood test accurately tracks HPV-linked head and neck cancer

Bhisham Chera, MD, and Gaorav Gupta, MD, PhD, led a study of a blood test to accurately detect HPV-linked head and neck cancer recurrence and confirm when there was no evidence of disease.

Study finds blood test accurately tracks HPV-linked head and neck cancer - Read More…